PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 5, 20260 citationsOpen Access

A pH-Responsive Copper-Chelate Antimicrobial Platform for Targeted Copper Ion Release at Sites of Infection

View Full Paper
MTMotoji Tajima

Key Points

  • This study aims to develop a pH-responsive system for releasing copper ions at infection sites to combat microbial infections.
  • Developed a copper-chelate complex using EDTA and HEDTA.
  • Evaluated antibacterial activity against Escherichia coli under acidic conditions.
  • Conducted clinical observations in patients with periodontal disease.
  • Copper-chelate complexes showed significant antibacterial activity against Escherichia coli at acidic pH levels.
  • Preliminary clinical observations indicated symptom improvement in periodontal disease patients.
  • No adverse effects were reported during the study.

Abstract

Copper ions possess broad-spectrum antimicrobial activity; however, maintaining biologically active copper ions in aqueous environments remains challenging because of precipitation and instability. This study describes a pH-responsive antimicrobial system utilizing copperchelate complexes based on ethylenediaminetetraacetic acid (EDTA) and N-(2hydroxyethyl)ethylenediamine-N,N',N'-triacetic acid (HEDTA). The proposed mechanism exploits the acidic microenvironment associated with infection and inflammation. Under acidic conditions, the copper-chelate complex partially dissociates, releasing biologically active copper ions capable of exerting antimicrobial activity against microorganisms. Experimental evaluation demonstrated antibacterial activity against Escherichia coli under acidic conditions, while preliminary clinical observations in periodontal disease patients demonstrated improvement in clinical symptoms without observed adverse effects. These findings suggest that copper-chelate systems may function as targeted antimicrobial platforms with potential applications in oral medicine, wound care, infection control, and nonantibiotic antimicrobial therapies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Motoji Tajima (2026) studied this question.

synapsesocial.com/papers/6a2268f9763171746d5477d3https://doi.org/10.5281/zenodo.20518612
Ask AI
Helpful
Bookmark
Share
View Full Paper